A
Andrey Morgun
Researcher at Oregon State University
Publications - 100
Citations - 3970
Andrey Morgun is an academic researcher from Oregon State University. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 24, co-authored 80 publications receiving 2333 citations. Previous affiliations of Andrey Morgun include National Institutes of Health & Ohio State University.
Papers
More filters
Journal ArticleDOI
Role of gut microbiota in type 2 diabetes pathophysiology.
Manoj Gurung,Zhipeng Li,Hannah You,Richard R. Rodrigues,Donald B. Jump,Andrey Morgun,Natalia Shulzhenko +6 more
TL;DR: Evidence from 42 human studies reporting microbial associations with disease, and supporting preclinical studies or clinical trials using treatments with probiotics are identified, found the genera of Bifidobacterium, Bacteroides, Faecalibacteriaium, Akkermansia and Roseburia were negatively associated with T2D, while theGenera of Ruminococcus, Fusobacteria, and Blautia were positively associated withT2D.
Journal ArticleDOI
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
Diwakar Davar,Amiran K. Dzutsev,John A. McCulloch,Richard R. Rodrigues,Joe Marc Chauvin,Robert M. Morrison,Richelle DeBlasio,Carmine Menna,Quanquan Ding,Ornella Pagliano,Bochra Zidi,Shuowen Zhang,Jonathan H. Badger,Marie Vétizou,Alicia M. Cole,Miriam R. Fernandes,Stephanie Prescott,Raquel Galvão Figueredo Costa,Ascharya K. Balaji,Andrey Morgun,Ivan Vujkovic-Cvijin,Hong Wang,Amir A. Borhani,Marc Schwartz,Howard M. Dubner,Scarlett J. Ernst,Amy Rose,Yana G. Najjar,Yasmine Belkaid,John M. Kirkwood,Giorgio Trinchieri,Hassane M. Zarour +31 more
TL;DR: In this article, a clinical trial evaluated the safety and efficacy of responder-derived fecal microbiota transplantation (FMT) together with anti-programmed cell death protein 1 (PD-1) therapy for patients with advanced melanoma.
Journal ArticleDOI
Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut
Natalia Shulzhenko,Andrey Morgun,Andrey Morgun,William W. L. Hsiao,Michele A. Battle,Michael Yao,Oksana Gavrilova,Marlene Orandle,Lloyd Mayer,Andrew J. Macpherson,Kathy D. McCoy,Kathy D. McCoy,Claire M. Fraser-Liggett,Polly Matzinger +13 more
TL;DR: Gene expression patterns in gut biopsies from individuals with common variable immunodeficiency or with HIV infection and intestinal malabsorption were very similar to those of the B cell–deficient mice, providing a possible explanation for a longstanding enigmatic association between immunodficiency and defective lipid absorption in humans.
Journal ArticleDOI
Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks
Andrey Morgun,Amiran Dzutsev,Xiaoxi Dong,Renee L. Greer,D. Joseph Sexton,Jacques Ravel,Martin Schuster,William W. L. Hsiao,Polly Matzinger,Natalia Shulzhenko +9 more
TL;DR: A new bioinformatics approach is described that predicts microbial components that regulate host functions and establishes a comprehensive resource on what, why and how antibiotics affect the gut in a widely used mouse model of microbiota depletion by antibiotics.
Journal ArticleDOI
Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism
Renee L. Greer,Xiaoxi Dong,Ana Carolina Franco de Moraes,Ryszard A. Zielke,Gabriel Fernandes,Ekaterina Peremyslova,Stephany Vasquez-Perez,Alexi A. Schoenborn,Everton Padilha Gomes,Alexandre C. Pereira,Sandra Roberta Gouvea Ferreira,Michael Yao,Ivan J. Fuss,Warren Strober,Aleksandra E. Sikora,Gregory A. Taylor,Ajay S. Gulati,Andrey Morgun,Natalia Shulzhenko +18 more
TL;DR: It is shown that the gut microbe Akkermansia muciniphila can mediate negative effects of IFNγ on glucose tolerance in mice and humans, and Irgm1 is identified as anIFNγ-regulated gene in the mouse ileum that controls gut A. muc iniphila levels.